TY - JOUR
T1 - Women’s perspectives on the acceptability and feasibility of an HPV screen-and-treat approach to cervical cancer prevention in Iquitos, Peru
T2 - a qualitative study
AU - the Proyecto Precancer Study Group
AU - Morse, Rachel M.
AU - Brown, Joanna
AU - Noble, Helen E.
AU - Ríos López, E. Jennifer
AU - Kohler-Smith, Anna
AU - Soto, Sandra
AU - del Cuadro, Daniel Lenin
AU - Gonzales Díaz, Karina
AU - Figueredo Escudero, Magaly
AU - Vásquez del Aguila, Giannina
AU - Carrillo Jara, Lita E.
AU - Silva Delgado, Hermann F.
AU - Palacios, Victor A.
AU - Santos-Ortiz, Carlos
AU - Gravitt, Patti E.
AU - Paz-Soldan, Valerie A.
AU - Del Carpio-Morgan, Meda
AU - Garcia Satalay, Esther Y.
AU - Gilman, Sarah D.
AU - Jerónimo, José
AU - Jorges, Alcedo
AU - Jurczuk, Magdalena
AU - Kosek, Margaret
AU - Ladrón de Guevarra, Gabriela
AU - Lopez Liñán, Renso
AU - Matos Orbegozo, Andrea
AU - Marín, Jaime
AU - Meza, Graciela
AU - Ríos Reátegui, Reyles
AU - Román, Karina
AU - Rositch, Anne F.
AU - Tangoa, Nolberto
AU - Vásquez Vásquez, Javier
AU - Vásquez del Aguila, Giannina
AU - Zevallos, Karen
N1 - Publisher Copyright:
© 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - Background: The objective of this study was to explore women’s experiences of a screen-and-treat approach with ablative therapy (referred to by the Spanish acronym TVT-TA) as a method of treatment following a positive HPV test in Iquitos, Peru. Methods: A total of 111 in-depth interviews were conducted with 47 HPV positive women who attended the TVT-TA procedure at a primary-level healthcare facility. Interviews were conducted immediately before, immediately after, and six-weeks after TVT-TA. Results: Most interviewed women reported experiencing moderate pain during ablative therapy and minimal pain immediately after and six weeks after ablative therapy. Women also stated that the pain was less intense than they had expected. The most common physical after-effects of treatment were bleeding and vaginal odor. Women experienced oscillating emotions with fear upon receiving a positive HPV result, calming after hearing about ablative therapy treatment, worry about pain from the treatment itself, relaxation with counseling about the procedure, and relief following treatment. Conclusions: Nearly all participants emphasized that they were pleased with the TVT-TA process even if they had experienced pain during TVT-TA, recommended that TVT-TA be expanded and available to more women, and stated that TVT-TA was faster and easier than expected. This study found that TVT-TA is a feasible and acceptable means of treating HPV according to the women receiving the treatment.
AB - Background: The objective of this study was to explore women’s experiences of a screen-and-treat approach with ablative therapy (referred to by the Spanish acronym TVT-TA) as a method of treatment following a positive HPV test in Iquitos, Peru. Methods: A total of 111 in-depth interviews were conducted with 47 HPV positive women who attended the TVT-TA procedure at a primary-level healthcare facility. Interviews were conducted immediately before, immediately after, and six-weeks after TVT-TA. Results: Most interviewed women reported experiencing moderate pain during ablative therapy and minimal pain immediately after and six weeks after ablative therapy. Women also stated that the pain was less intense than they had expected. The most common physical after-effects of treatment were bleeding and vaginal odor. Women experienced oscillating emotions with fear upon receiving a positive HPV result, calming after hearing about ablative therapy treatment, worry about pain from the treatment itself, relaxation with counseling about the procedure, and relief following treatment. Conclusions: Nearly all participants emphasized that they were pleased with the TVT-TA process even if they had experienced pain during TVT-TA, recommended that TVT-TA be expanded and available to more women, and stated that TVT-TA was faster and easier than expected. This study found that TVT-TA is a feasible and acceptable means of treating HPV according to the women receiving the treatment.
KW - Ablative therapy
KW - Acceptability
KW - Cervical cancer
KW - Screen-and-treat
KW - Thermal ablation
UR - https://www.scopus.com/pages/publications/85139468580
U2 - 10.1186/s12905-022-01943-3
DO - 10.1186/s12905-022-01943-3
M3 - Artículo
C2 - 36217187
AN - SCOPUS:85139468580
SN - 1472-6874
VL - 22
JO - BMC Women's Health
JF - BMC Women's Health
IS - 1
M1 - 414
ER -